I've been reviewing the UK government's proposed "patent box" tax incentive this week (click here) with my tax colleagues and have found no mention of SPCs at all.
I am sure UK pharma and biotech have not overlooked the issue and would imagine that responses to the proposal, due this month, will pick this point up, but I am curious to know how SPCs are treated in other jurisdictions with patent box tax incentives...Belgium and the Netherlands to name two. All information gratefully received!
No comments:
Post a Comment